99342-8 |
Days since symptom started |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Days since symptom started |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.COVID |
|
99342-8 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Sx |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99343-6 |
Days since symptom finished |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Days since symptom finished |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.COVID |
|
99343-6 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Sx |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99344-4 |
Sought medical attention for symptoms |
Find |
^Patient |
RptPeriod |
Nom |
|
|
ACTIVE |
Sought medical attention for symptoms |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
99344-4 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Nominal; Report period; Sought med attention for symp; Survey; SURVEY.GNHLTH; Sx |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99345-1 |
Type of medical attention accessed |
Type |
^Patient |
RptPeriod |
Nom |
|
|
ACTIVE |
Type of medical attention accessed |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
99345-1 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Nominal; Report period; Survey; SURVEY.GNHLTH; Typ; Type of medi attention accessed |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99346-9 |
Temperature taken |
Find |
^Patient |
RptPeriod |
Ord |
|
|
ACTIVE |
Temperature taken Reporting Period |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
99346-9 |
|
|
|
|
Observation |
|
|
|
0 |
Temperature taken RptPeriod |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Ordinal; P prime; QL; Qual; Qualitative; Report period; Screen; Temp |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99347-7 |
Body temperature.max |
Temp |
^Patient |
RptPeriod |
Qn |
|
|
ACTIVE |
Maximum body temperature Reporting Period |
|
ADD |
DefinitionDescription |
|
|
deg |
|
|
|
|
|
|
H&P.HX |
|
99347-7 |
|
|
|
|
Observation |
|
|
|
0 |
Body temp.max RptPeriod |
|
|
|
N |
|
Bdy temp; bod; Bodies; Body temp.max; H+P; H+P.HX; Largest; Maximal; Maximum; P prime; Peak; QNT; Quan; Quant; Quantitative; Report period; Temp; Temperature |
2.72 |
2.72 |
|
|
|
|
|
|
|
deg |
|
|
|
0 |
99348-5 |
Close contact with COVID-19 in last 2W |
Find |
^Patient |
2W |
Nom |
|
|
ACTIVE |
Close contact with COVID-19 in last 2W |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.COVID |
|
99348-5 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
14 days; 2 weeks; 2019 Novel Coronavirus; 2019-nCoV; Close contact with CO-19 in last 2W; Coronavirus disease 2019; COVID19; Finding; Findings; Nominal; Past; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99349-3 |
Has or had COVID-19 |
Hx |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Has or had COVID-19 |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.COVID |
|
99349-3 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; History; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9935-8 |
Q wave depth.lead V5 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
Q wave depth in lead V5 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9935-8 |
|
EKG |
|
|
Observation |
|
|
|
0 |
Q wave Dpth L-V5 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth Lead; Q wave Dpth L-V5; QNT; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
99350-1 |
Date of first infection onset |
Date |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Date of first infection onset |
|
ADD |
DefinitionDescription |
|
|
MMDDYY |
|
|
|
|
|
|
SURVEY.COVID |
|
99350-1 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Nominal; Point in time; Random; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
{mm/dd/yyyy} |
|
|
|
0 |
99351-9 |
Informed of being at severe risk from COVID-19 due to an underlying health condition |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Informed of being at severe risk from COVID-19 due to an underlying health condition |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.COVID |
|
99351-9 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Sev risk C-19 b/c underlying hlth cond; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99352-7 |
Has health problems that require activity limits |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Has health problems that require activity limits |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
99352-7 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Activ; Actvty; Finding; Findings; Health prob require activity limits; Movements; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99353-5 |
Has health problems that require staying at home |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Has health problems that require staying at home |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
99353-5 |
|
|
|
|
Observation |
|
|
|
0 |
Health prob require stay home |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Health prob require stay home; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99354-3 |
Mobility device or aid is regularly used |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Mobility device or aid is regularly used |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
99354-3 |
|
|
|
|
Observation |
|
|
|
0 |
Mobility device reg used |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Mobility device reg used; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99355-0 |
Takes routine medication |
Find |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Takes routine medication |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
99355-0 |
|
|
|
|
Observation |
|
|
|
0 |
Takes routine med |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99356-8 |
Influenza virus vaccination received in last 12Mo |
Find |
^Patient |
12Mo |
Ord |
|
|
ACTIVE |
Influenza virus vaccination received in last 12 months |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
99356-8 |
|
|
|
|
Observation |
|
|
|
0 |
Flu vacc last 12Mo |
|
|
|
N |
|
1 year; 12Mos; Finding; Findings; Flu vacc last 12Mo; FLUV; H+P; H+P.HX; Immunizations; Influ; Influenza vacc received; Ordinal; P prime; Past; QL; Qual; Qualitative; Screen; Vaccine |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99357-6 |
COVID-19 health questions panel |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
COVID-19 health questions panel |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.COVID |
|
99357-6 |
|
|
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Pan; Panl; Pnl; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Survey |
2.72 |
2.72 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
99359-2 |
Person who performed clinical measurement |
Type |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Person who performed clinical measurement |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
99359-2 |
|
|
|
|
Observation |
|
|
|
0 |
Clinical measurement by |
|
|
|
N |
|
Clinical measurement by; H+P; H+P.HX; Nominal; P prime; Persons; Point in time; Random; Typ; World Heatlth Organization |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9936-6 |
Q wave depth.lead V6 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
Q wave depth in lead V6 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9936-6 |
|
EKG |
|
|
Observation |
|
|
|
0 |
Q wave Dpth L-V6 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth Lead; Q wave Dpth L-V6; QNT; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
99360-0 |
Bovine serum albumin Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Bovine serum albumin (BSA) IgG Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99360-0 |
|
|
|
|
Both |
|
|
|
0 |
BSA IgG-mCnc |
|
|
|
N |
|
a165; ABS; Aby; Alb; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beef; Bos spp; BSA; e204; Fraction V; Immune globulin G; Immunoglobulin G; Level; Mass concentration; nBos d 6; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Re204; Ser; Serum; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
99361-8 |
Horse hair+Horse dander Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Horse hair+Horse dander IgG Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99361-8 |
|
|
|
|
Both |
|
|
|
0 |
Horse Hair+Dander IgG-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e003; e3; Equus spp; Horse Hair+Dander; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
99362-6 |
Euroglyphus maynei Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Euroglyphus maynei IgG Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99362-6 |
|
|
|
|
Both |
|
|
|
0 |
E maynei IgG-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; d74; E maynei; HDM; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Mite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
99363-4 |
Triticum spelta Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Spelt IgG Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99363-4 |
|
|
|
|
Both |
|
|
|
0 |
Spelt IgG-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f124; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spelt; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
99364-2 |
Ovalbumin Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Ovalbumin IgG Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99364-2 |
|
|
|
|
Both |
|
|
|
0 |
Ovalb IgG-mCnc |
|
|
|
N |
|
a359; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f232; Immune globulin G; Immunoglobulin G; Level; Mass concentration; nGal d 2; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
99365-9 |
Sheep milk Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Sheep milk IgG Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99365-9 |
|
|
|
|
Both |
|
|
|
0 |
Sheep Milk IgG-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f325; f43; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Ovine; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf325; Serum; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |